Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years
- PMID: 17382108
- PMCID: PMC2897232
- DOI: 10.1016/j.jpeds.2006.12.013
Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years
Abstract
Objective: To determine whether postnatal dexamethasone (DEX) exposure affects pulmonary outcomes at school age in children born with very low birth weight (VLBW).
Study design: Follow-up study of 68 VLBW children who participated in a randomized controlled trial of postnatal DEX. Pulmonary function was assessed by spirometry. Current asthma status was obtained from a parent.
Results: Sixty-eight percent of the placebo group had below-normal forced expiratory volume in 1 second (FEV1), compared with 40% of the DEX group (chi2 = 4.84; P = .03), with trends for lower forced vital capacity (FVC) and FEV1 values in the placebo group. Fifty percent of the placebo group and 34% of DEX group had below normal FEV1/FVC (chi2 =1.59; P =.21). Parent-reported prevalence of asthma did not differ between groups. Logistic regression analysis suggested that the positive effects of DEX on pulmonary function at follow-up were mediated in part by shortened exposure to mechanical ventilation.
Conclusions: Postnatal DEX exposure was associated with higher expiratory flow with no adverse effects on pulmonary outcomes at school age. The prevalences of asthma and impaired pulmonary function underscore the influence of neonatal illness on health at school age, and stress the importance of repeated follow-up examinations of these children.
Comment in
-
Postnatal steroids for bronchopulmonary dysplasia: where are we now?J Pediatr. 2007 Apr;150(4):327-8. doi: 10.1016/j.jpeds.2006.12.041. J Pediatr. 2007. PMID: 17382102 No abstract available.
Similar articles
-
Effect of dexamethasone exposure on the neonatal unit on the school age lung function of children born very prematurely.PLoS One. 2018 Jul 9;13(7):e0200243. doi: 10.1371/journal.pone.0200243. eCollection 2018. PLoS One. 2018. PMID: 29985964 Free PMC article. Clinical Trial.
-
Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age.J Pediatr. 2014 Jan;164(1):40-45.e4. doi: 10.1016/j.jpeds.2013.07.045. Epub 2013 Sep 20. J Pediatr. 2014. PMID: 24055328
-
Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.N Engl J Med. 2004 Mar 25;350(13):1304-13. doi: 10.1056/NEJMoa032089. N Engl J Med. 2004. PMID: 15044641 Clinical Trial.
-
Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.Cochrane Database Syst Rev. 2024 Apr 10;4(4):CD013271. doi: 10.1002/14651858.CD013271.pub2. Cochrane Database Syst Rev. 2024. PMID: 38597338 Free PMC article. Review.
-
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Neonatology. 2015. PMID: 26044104 Review.
Cited by
-
Aerobic fitness and physical activity levels of children born prematurely following randomization to postnatal dexamethasone.J Pediatr. 2011 Jan;158(1):65-70. doi: 10.1016/j.jpeds.2010.07.007. Epub 2010 Aug 21. J Pediatr. 2011. PMID: 20732688 Free PMC article. Clinical Trial.
-
Effect of dexamethasone exposure on the neonatal unit on the school age lung function of children born very prematurely.PLoS One. 2018 Jul 9;13(7):e0200243. doi: 10.1371/journal.pone.0200243. eCollection 2018. PLoS One. 2018. PMID: 29985964 Free PMC article. Clinical Trial.
-
Predictors of wheezing in prematurely born children.J Obstet Gynecol Neonatal Nurs. 2008 May-Jun;37(3):262-73. doi: 10.1111/j.1552-6909.2008.00238.x. J Obstet Gynecol Neonatal Nurs. 2008. PMID: 18507597 Free PMC article.
-
Postnatal corticosteroids for bronchopulmonary dysplasia.Clin Perinatol. 2009 Mar;36(1):177-88. doi: 10.1016/j.clp.2008.09.016. Clin Perinatol. 2009. PMID: 19161874 Free PMC article.
-
Postnatal dexamethasone, respiratory and neurodevelopmental outcomes at two years in babies born extremely preterm.PLoS One. 2017 Jul 19;12(7):e0181176. doi: 10.1371/journal.pone.0181176. eCollection 2017. PLoS One. 2017. PMID: 28723921 Free PMC article.
References
-
- Final natality data. National Center for Health Statistics Centers for Disease Control and Prevention; 2005.
-
- Stevenson DK, Wright LL, Lemons JA, Oh W, Korones SB, Papile LA, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol. 1998;179:1632–9. - PubMed
-
- Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network Pediatrics. 2001;107:E1. - PubMed
-
- Palta M, Sadek M, Barnet JH, Evans M, Weinstein MR, McGuinness G, et al. Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. Newborn Lung Project J Pediatr. 1998;132:57–63. - PubMed
-
- Palta M, Sadek-Badawi M, Sheehy M, Albanese A, Weinstein M, McGuinness G, et al. Respiratory symptoms at age 8 years in a cohort of very low birth weight children. Am J Epidemiol. 2001;154:521–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical